Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.71).

As of September 30, 2018, the company\'s cash, cash equivalents, short-term investments and restricted cash were $13.2 million. Total operating expenses for the three and nine months ended September 30, 2018 were $3.3 million and $9.1 million, respectively. Total net loss for the three and nine months ended September 30, 2018 was $3.2 million and $9.1 million, respectively

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.